Chugai Pharmaceutical (OTCMKTS:CHGCY) Shares Gap Down – Should You Sell?

Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (OTCMKTS:CHGCY)’s share price gapped down before the market opened on Friday . The stock had previously closed at $26.82, but opened at $25.29. Chugai Pharmaceutical shares last traded at $25.9250, with a volume of 55,853 shares traded.

Chugai Pharmaceutical Trading Down 3.3%

The stock’s 50 day moving average is $26.49 and its two-hundred day moving average is $24.22. The stock has a market capitalization of $85.35 billion, a price-to-earnings ratio of 32.42 and a beta of 0.63.

Chugai Pharmaceutical (OTCMKTS:CHGCY) last posted its quarterly earnings results on Friday, October 24th. The company reported $0.23 earnings per share for the quarter. The firm had revenue of $2.26 billion for the quarter. Chugai Pharmaceutical had a return on equity of 20.63% and a net margin of 32.74%. On average, research analysts anticipate that Chugai Pharmaceutical Co., Ltd. Unsponsored ADR will post 0.74 earnings per share for the current year.

About Chugai Pharmaceutical

Chugai Pharmaceutical Co, Ltd. is a Japan-based biopharmaceutical company headquartered in Tokyo that focuses on the discovery, development, manufacture and marketing of prescription medicines. The company develops both biologics and small-molecule therapies, with particular emphasis on oncology and immunology as well as treatments for bone and metabolic disorders. Chugai’s activities span the full drug lifecycle from early research and clinical development through regulatory approval, manufacturing and post-marketing support.

Chugai is known for its research-driven approach and its work on monoclonal antibodies and other biologic therapeutics.